News Search Results
Aug 28, 2026, 14:38 ET 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Aug 06, 2026, 16:02 ET 10x Genomics Reports Second Quarter 2026 Financial Results
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Aug 06, 2026, 10:30 ET Multiomics Market worth $5.70 billion by 2031 - Exclusive Report by MarketsandMarkets™
Multiomics companies include 10x Genomics, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bruker Corporation (US), Agilent Technologies, Inc. (US), Danaher Corporation
More news about: MarketsandMarkets
Jul 29, 2026, 09:00 ET 10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
clinical reporting frameworks to support personalized treatment planning and molecular tumor board decision-making.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Jul 15, 2026, 16:05 ET 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Jul 09, 2026, 10:46 ET Global Pharmacogenomic Testing Service Market to Register Stunning Growth at a CAGR of ~12% by 2034 | DelveInsight
QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Polymerase Chain Reaction,
More news about: DelveInsight Business Research, LLP
Jul 02, 2026, 10:46 ET Global DNA Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight
QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Polymerase Chain Reaction,
More news about: DelveInsight Business Research, LLP
Jun 17, 2026, 09:00 ET 10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
advance the scientific understanding of treatment response in bladder cancer and support future diagnostic applications.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Jun 12, 2026, 06:02 ET 12 Press Releases You Need to See This Week
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech GroupThe acquisition builds on 10x's broader vision to enable multimodal
More news about: PR Newswire
Jun 09, 2026, 09:00 ET 10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
advance human health.The terms of the transaction were not disclosed. 10x Genomics believes the transaction will not meaningfully impact its near-term financial outlook.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery
More news about: 10x Genomics, Inc.
May 08, 2026, 11:44 ET Advaita Bio představuje iSCanGuide™: Integrovanou analýzu jednobuněčné a prostorové transkriptomiky využívající infrastrukturu s GPU akcelerací
datům v každé fázi.Analýza prostorové transkriptomiky: Mapujte genovou expresi v jejím nativním tkáňovém kontextu s plnou podporou 10x Genomics Visium (Standard/HD) a Xenium. Vizualizujte prostorové rozložení buněk a identifikujte prostorově variabilní geny – to vše ve stejném prostředí,
More news about: Advaita Bio
May 07, 2026, 16:05 ET 10x Genomics Reports First Quarter 2026 Financial Results
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
May 07, 2026, 12:08 ET Advaita Bio wprowadza iSCanGuide™: ujednoliconą analizę transkryptomiki pojedynczych komórek i przestrzennej opartą na infrastrukturze akcelerowanej przez GPU
- Analiza transkryptomiki przestrzennej: mapowanie ekspresji genów w ich naturalnym kontekście tkankowym z pełną obsługą platform 10x Genomics Visium (Standard/HD) oraz Xenium. Wizualizacja przestrzennych rozmieszczeń komórek i identyfikacja genów zmiennych przestrzennie - wszystko w tym
More news about: Advaita Bio
May 07, 2026, 12:04 ET Advaita Bio spúšťa iSCanGuide™: platformu pre analýzu jednobunkových a priestorových transkriptomických dát s akceleráciou GPU
každej fáze.Analýza priestorovej transkriptomiky: mapuje génovú expresiu v jej prirodzenom tkanivovom kontexte s plnou podporou pre 10x Genomics Visium (Standard/HD) a Xenium. Vizualizuje priestorové rozloženie buniek a identifikuje priestorovo variabilné gény – to všetko v rovnakom prostredí
More news about: Advaita Bio
May 07, 2026, 11:52 ET Advaita Bio lance iSCanGuide™ : analyse unifiée de la transcriptomique unicellulaire et spatiale, reposant sur une infrastructure optimisée par GPU
transcriptomique spatiale : cartographie de l'expression des gènes dans leur contexte tissulaire d'origine grâce à la prise en charge complète de 10x Genomics Visium (Standard/HD) et Xenium. Visualisez la distribution spatiale de cellules et identifiez les gènes à variation spatiale, le tout dans le même
More news about: Advaita Bio
May 07, 2026, 10:55 ET Advaita Bio lanza iSCanGuide™
etapa.Análisis de transcriptómica espacial: Mapea la expresión génica en su contexto tisular nativo con compatibilidad total con 10x Genomics Visium (Standard/HD) y Xenium. Visualiza distribuciones celulares espaciales e identifica genes espacialmente variables, todo dentro del mismo entorno
More news about: Advaita Bio
May 07, 2026, 10:54 ET Advaita Bio bringt iSCanGuide™ auf den Markt: Vereinheitlichte Analyse für Einzelzell-Transkriptomik und räumliche Transkriptomik, gestützt auf GPU-beschleunigte Infrastruktur
anpassen.Analyse der räumlichen Transkriptomik: Erfasst die Genexpression in ihrem nativen Gewebekontext mit vollständiger Unterstützung für 10x Genomics Visium (Standard/HD) und Xenium. Räumliche Zellverteilungen lassen sich visualisieren und räumlich variable Gene identifizieren, und zwar innerhalb
More news about: Advaita Bio
May 07, 2026, 07:45 ET Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
your data at every stage.Spatial Transcriptomics Analysis: Map gene expression in its native tissue context with full support for 10x Genomics Visium (Standard/HD) and Xenium. Visualize spatial cell distributions and identify spatially variable genes — all within the same environment used
More news about: Advaita Bio
May 07, 2026, 07:45 ET Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
your data at every stage.Spatial Transcriptomics Analysis: Map gene expression in its native tissue context with full support for 10x Genomics Visium (Standard/HD) and Xenium. Visualize spatial cell distributions and identify spatially variable genes — all within the same environment used
More news about: Advaita Bio
Apr 29, 2026, 16:05 ET 10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Apr 29, 2026, 09:00 ET The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
VPTDF), Senseonics (NASDAQ: SENS), TransMedics Group (NASDAQ: TMDX), WELL Health Technologies (TSX: WELL) (OTCQX: WHTCF), and 10x Genomics (NASDAQ: TXG).
More news about: Equity Insider
Apr 29, 2026, 05:00 ET Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biology
Columbia University, University of Washington, ETH Zurich, and the Genome Institute of Singapore, in collaboration with industry partners 10x Genomics and Ultima Genomics."Biohub's investments in efforts like the Billion Cells Project and CELLxGENE are generating datasets that are already
More news about: Biohub
Apr 18, 2026, 22:00 ET 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Apr 15, 2026, 16:05 ET 10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Mar 25, 2026, 07:00 ET Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
www.bioptimus.comMedia Contact: [email protected] 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: Bioptimus